INTERNATIONAL PATENT: SUTRO BIOPHARMA, INC. FILES APPLICATION FOR "ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODIES OR ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES"

GENEVA, April 21 -- SUTRO BIOPHARMA, INC. (111 Oyster Point BlvdSouth San Francisco, California 94080) filed a patent application (PCT/US2024/051143) for "ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODIES OR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES" on Oct 11, 2024. With publication no. WO/2025/081117, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Grace Jungeun (c/o Sutro Biopharma, Inc.111 O...